Is Friedreich’s ataxia treatment covered by insurance?

Insurance policy coverage varies depending on the specific insurer and plan. It’s recommended that people with Friedreich’s ataxia consult with their specific insurance provider to understand what forms of coverage are available for them. In the case of Skyclarys (omaveloxolone), the first and currently only therapy approved for Friedreich’s ataxia in the U.S., the treatment’s developer, Reata Pharmaceuticals, offers support for those prescribed one of their medicines, regardless of insurance status.